Please use this identifier to cite or link to this item: https://doi.org/10.1002/mas.20356
Title: Cancer proteomics
Authors: Tan, H.T. 
Lee, Y.H.
Chung, M.C.M.
Keywords: biomarkers
cancer
proteomics
quantitative proteomics strategies
Issue Date: Sep-2012
Citation: Tan, H.T., Lee, Y.H., Chung, M.C.M. (2012-09). Cancer proteomics. Mass Spectrometry Reviews 31 (5) : 583-605. ScholarBank@NUS Repository. https://doi.org/10.1002/mas.20356
Abstract: Cancer presents high mortality and morbidity globally, largely due to its complex and heterogenous nature, and lack of biomarkers for early diagnosis. A proteomics study of cancer aims to identify and characterize functional proteins that drive the transformation of malignancy, and to discover biomarkers to detect early-stage cancer, predict prognosis, determine therapy efficacy, identify novel drug targets, and ultimately develop personalized medicine. The various sources of human samples such as cell lines, tissues, and plasma/serum are probed by a plethora of proteomics tools to discover novel biomarkers and elucidate mechanisms of tumorigenesis. Innovative proteomics technologies and strategies have been designed for protein identification, quantitation, fractionation, and enrichment to delve deeper into the oncoproteome. In addition, there is the need for high-throughput methods for biomarker validation, and integration of the various platforms of oncoproteome data to fully comprehend cancer biology. © 2012 Wiley Periodicals, Inc. Mass Spec Rev 31:583-605, 2012 Copyright © 2012 Wiley Periodicals, Inc.
Source Title: Mass Spectrometry Reviews
URI: http://scholarbank.nus.edu.sg/handle/10635/109222
ISSN: 02777037
DOI: 10.1002/mas.20356
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

37
checked on Aug 19, 2019

WEB OF SCIENCETM
Citations

39
checked on Aug 19, 2019

Page view(s)

50
checked on Aug 16, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.